Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis

BackgroundThe survival of early placement (within 72h after admission) of transjugular intrahepatic portosystemic shunts (early-TIPS) in patients with cirrhosis and acute variceal bleeding (AVB) is controversial.ObjectivesWe performed a systemic review and meta-analysis to assess whether early-TIPS...

Full description

Bibliographic Details
Main Authors: Shuang Li, Chao Zhang, Lu-Lu Lin, Qi Wang, Hong-Xia Zuo, Ai-Ling Zhan, Jie Luo, Yu-Ming Niu, Guo-Qing Zhong
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00603/full
_version_ 1818178486578184192
author Shuang Li
Chao Zhang
Lu-Lu Lin
Qi Wang
Hong-Xia Zuo
Ai-Ling Zhan
Jie Luo
Yu-Ming Niu
Guo-Qing Zhong
author_facet Shuang Li
Chao Zhang
Lu-Lu Lin
Qi Wang
Hong-Xia Zuo
Ai-Ling Zhan
Jie Luo
Yu-Ming Niu
Guo-Qing Zhong
author_sort Shuang Li
collection DOAJ
description BackgroundThe survival of early placement (within 72h after admission) of transjugular intrahepatic portosystemic shunts (early-TIPS) in patients with cirrhosis and acute variceal bleeding (AVB) is controversial.ObjectivesWe performed a systemic review and meta-analysis to assess whether early-TIPS could improve survival in patients with cirrhosis and acute variceal bleeding.MethodsA systematic search of the literature was conducted in PubMed, EMBASE, and Cochrane Library published before 25 June 2019 for eligible studies that compared early-TIPS with a combination of endoscopic variceal ligation (EVL) and pharmacotherapy in the therapeutic effect in AVB patients.ResultsA total of five studies with 1,754 participants were enrolled. The early-TIPS demonstrated a significant improvement in prevention of treatment failure (OR=0.11,95%CI=0.05-0.23), 6-weeks mortality (OR=0.24,95%CI=0.13-0.46), rebleeding within 6 weeks (OR=0.21,95%CI=0.12-0.36), rebleeding within 1 year (OR=0.16,95%CI=0.07-0.36), new or worsening ascites (OR=0.33,95%CI=0.21-0.53), except in encephalopathy (OR=1.29,95%CI=0.996-1.67). For 1-year mortality, a significant prior effect was also observed in early-TIPS (OR=0.64,95%CI=0.46-0.90), and the beneficial effect in Child-Pugh C patients (OR=0.35,95%CI=0.18-0.68) was equal to Child-Pugh B patients (OR=0.34,95%CI=0.25-0.58). No difference in liver transplantation and mortality caused by liver failure was observed.ConclusionsEarly covered-TIPS could be recommended for the management of AVB patients in cirrhosis demonstrating a significant improvement in treatment failure, both short- and long-term mortality, rebleeding risk, and new or worsening ascites compared to standard therapy, especially for high-risk AVB patients. It will also apply to patients with Child-Pugh A until solutions to prevent hepatic encephalopathy in future research are found.
first_indexed 2024-12-11T20:48:45Z
format Article
id doaj.art-37556d544bb649f5a6a4fea2a8b9f1f9
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T20:48:45Z
publishDate 2020-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-37556d544bb649f5a6a4fea2a8b9f1f92022-12-22T00:51:17ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-05-011110.3389/fphar.2020.00603504105Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysisShuang Li0Chao Zhang1Lu-Lu Lin2Qi Wang3Hong-Xia Zuo4Ai-Ling Zhan5Jie Luo6Yu-Ming Niu7Guo-Qing Zhong8Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Anesthesiology, Central Hospital of Shanghai Songjiang District, Shanghai, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Obstetrical, Jining No.1 People's Hospital, Jining, ChinaBackgroundThe survival of early placement (within 72h after admission) of transjugular intrahepatic portosystemic shunts (early-TIPS) in patients with cirrhosis and acute variceal bleeding (AVB) is controversial.ObjectivesWe performed a systemic review and meta-analysis to assess whether early-TIPS could improve survival in patients with cirrhosis and acute variceal bleeding.MethodsA systematic search of the literature was conducted in PubMed, EMBASE, and Cochrane Library published before 25 June 2019 for eligible studies that compared early-TIPS with a combination of endoscopic variceal ligation (EVL) and pharmacotherapy in the therapeutic effect in AVB patients.ResultsA total of five studies with 1,754 participants were enrolled. The early-TIPS demonstrated a significant improvement in prevention of treatment failure (OR=0.11,95%CI=0.05-0.23), 6-weeks mortality (OR=0.24,95%CI=0.13-0.46), rebleeding within 6 weeks (OR=0.21,95%CI=0.12-0.36), rebleeding within 1 year (OR=0.16,95%CI=0.07-0.36), new or worsening ascites (OR=0.33,95%CI=0.21-0.53), except in encephalopathy (OR=1.29,95%CI=0.996-1.67). For 1-year mortality, a significant prior effect was also observed in early-TIPS (OR=0.64,95%CI=0.46-0.90), and the beneficial effect in Child-Pugh C patients (OR=0.35,95%CI=0.18-0.68) was equal to Child-Pugh B patients (OR=0.34,95%CI=0.25-0.58). No difference in liver transplantation and mortality caused by liver failure was observed.ConclusionsEarly covered-TIPS could be recommended for the management of AVB patients in cirrhosis demonstrating a significant improvement in treatment failure, both short- and long-term mortality, rebleeding risk, and new or worsening ascites compared to standard therapy, especially for high-risk AVB patients. It will also apply to patients with Child-Pugh A until solutions to prevent hepatic encephalopathy in future research are found.https://www.frontiersin.org/article/10.3389/fphar.2020.00603/fullacute variceal bleedingcirrhosistransjugular intrahepatic portosystemic shuntendoscopic variceal ligationmeta-analysis
spellingShingle Shuang Li
Chao Zhang
Lu-Lu Lin
Qi Wang
Hong-Xia Zuo
Ai-Ling Zhan
Jie Luo
Yu-Ming Niu
Guo-Qing Zhong
Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis
Frontiers in Pharmacology
acute variceal bleeding
cirrhosis
transjugular intrahepatic portosystemic shunt
endoscopic variceal ligation
meta-analysis
title Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis
title_full Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis
title_fullStr Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis
title_full_unstemmed Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis
title_short Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis
title_sort early tips versus current standard therapy for acute variceal bleeding in cirrhosis patients a systemic review with meta analysis
topic acute variceal bleeding
cirrhosis
transjugular intrahepatic portosystemic shunt
endoscopic variceal ligation
meta-analysis
url https://www.frontiersin.org/article/10.3389/fphar.2020.00603/full
work_keys_str_mv AT shuangli earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis
AT chaozhang earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis
AT lululin earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis
AT qiwang earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis
AT hongxiazuo earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis
AT ailingzhan earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis
AT jieluo earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis
AT yumingniu earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis
AT guoqingzhong earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis